NASDAQ: XRTX
Xortx Therapeutics Inc Stock Ownership - Who owns Xortx Therapeutics?

Insider buying vs selling

Have Xortx Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when XRTX insiders and whales buy or sell their stock.

XRTX Shareholders

What type of owners hold Xortx Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC1.02%38,468$31.20kInstitution
Ubs Group Ag0.55%20,790$16.86kInstitution
National Bank Of Canada0.10%3,934$3.19kInstitution
Osaic Holdings Inc0.03%1,153$935.08Institution
Royal Bank Of Canada0.02%663$537.69Institution
Raymond James Financial Inc0.01%500$405.50Institution
Clearstead Advisors LLC0.01%277$224.65Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

XRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XRTX1.71%0.00%
ENVB7.21%16.79%
SLXN5.24%94.76%
GTBP5.58%33.91%
AZTR2.47%97.53%

Xortx Therapeutics Stock Ownership FAQ

Who owns Xortx Therapeutics?

Xortx Therapeutics (NASDAQ: XRTX) is owned by 1.71% institutional shareholders, 0.00% Xortx Therapeutics insiders, and 98.29% retail investors. Citadel Advisors LLC is the largest individual Xortx Therapeutics shareholder, owning 38,468.00 shares representing 1.02% of the company. Citadel Advisors LLC's Xortx Therapeutics shares are currently valued at $31.77k.

If you're new to stock investing, here's how to buy Xortx Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.